Synopsis
Synopsis
0
EU WC
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Dihydromorphinone
2. Dilaudid
3. Hydromorphon
4. Hydromorphone
5. Laudacon
6. Palladone
1. 71-68-1
2. Hydromorphone Hcl
3. Dilaudid
4. Palladone
5. Hymorphan
6. Exalgo
7. Dihydromorphinone Hydrochloride
8. Dilaudid-hp
9. L960up2krw
10. Hydromorphone Hydrochloride Cii
11. Nsc-117862
12. Dea No. 9150
13. (4r,4ar,7ar,12bs)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
14. 4,5-alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one Hydrochloride
15. Chebi:5791
16. Morphinone, Dihydro-, Hydrochloride
17. Einecs 200-762-6
18. Unii-l960up2krw
19. Nsc 117862
20. Hydromorphone Hydrochloride [usp]
21. Palladone (tn)
22. Dilaudid (tn)
23. (4r,4ar,7ar,12bs)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
24. Exalgo (tn)
25. 4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one Hydrochloride
26. Schembl30521
27. Hydromorphone Hydrochloride Usp
28. Chembl1237055
29. Dtxsid90991291
30. Morphinan-6-one, 4,5alpha-epoxy-3-hydroxy-17-methyl-, Hydrochloride
31. Hydromorphone Hydrochloride (jan/usp)
32. Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, Hydrochloride, (5alpha)-
33. Hydromorphone Hydrochloride [mi]
34. Morphinan-6-one, 4,5-alpha-epoxy-3-hydroxy-17-methyl-, Hydrochloride, (5'-alpha)-
35. Hydromorphone Hydrochloride [jan]
36. Hydromorphone Hydrochloride [mart.]
37. Hydromorphone Hydrochloride [vandf]
38. Hydromorphone Hydrochloride [who-dd]
39. D00839
40. Hydromorphone Hydrochloride [orange Book]
41. Hydromorphone Hydrochloride Cii [usp-rs]
42. Hydromorphone Hydrochloride [ep Monograph]
43. Hydromorphone Hydrochloride [usp Monograph]
44. Q27106892
45. 4,5.alpha.-epoxy-3-hydroxy-17-methylmorphinan-6-one Hydrochloride
46. Hydromorphone Hydrochloride Solution, Drug Standard, 1.0 Mg/ml In Methanol
47. Hydromorphone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
48. Hydromorphone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
49. Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, Hydrochloride (1:1), (5.alpha.)
50. Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, Hydrochloride, (5.alpha.)-
Molecular Weight | 321.8 g/mol |
---|---|
Molecular Formula | C17H20ClNO3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 321.1131712 g/mol |
Monoisotopic Mass | 321.1131712 g/mol |
Topological Polar Surface Area | 49.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 494 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Exalgo |
Drug Label | EXALGO tablets contain hydromorphone hydrochloride, a mu-opioid agonist.Hydromorphone hydrochloride USP is 4,5-epoxy-3-hydroxy-17-methlymorphinan-6-one hydrochloride. Hydromorphone hydrochloride is a white or almost white crystalline powder that... |
Active Ingredient | Hydromorphone hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 32mg; 12mg; 16mg; 8mg |
Market Status | Prescription |
Company | Mallinckrodt |
2 of 4 | |
---|---|
Drug Name | Hydromorphone hydrochloride |
PubMed Health | Hydromorphone |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg are supplied in tablet form for oral administration.Hydromorphone hydrochloride, a hydrogenated ketone of morphine, is an opioid analgesic.The chemical name of hydromorphone hydrochloride... |
Active Ingredient | Hydromorphone hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Injectable; Solution |
Route | Injection; Oral |
Strength | 2mg/ml; 1mg/ml; 8mg; 10mg/ml; 4mg; 4mg/ml; 12mg; 2mg; 16mg; 5mg/5ml |
Market Status | Prescription |
Company | Hospira; Actavis Labs Fl; Mallinckrodt; Roxane; Lannett; Elite Labs; Akorn; Barr |
3 of 4 | |
---|---|
Drug Name | Exalgo |
Drug Label | EXALGO tablets contain hydromorphone hydrochloride, a mu-opioid agonist.Hydromorphone hydrochloride USP is 4,5-epoxy-3-hydroxy-17-methlymorphinan-6-one hydrochloride. Hydromorphone hydrochloride is a white or almost white crystalline powder that... |
Active Ingredient | Hydromorphone hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 32mg; 12mg; 16mg; 8mg |
Market Status | Prescription |
Company | Mallinckrodt |
4 of 4 | |
---|---|
Drug Name | Hydromorphone hydrochloride |
PubMed Health | Hydromorphone |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg, and 8 mg are supplied in tablet form for oral administration.Hydromorphone hydrochloride, a hydrogenated ketone of morphine, is an opioid analgesic.The chemical name of hydromorphone hydrochloride... |
Active Ingredient | Hydromorphone hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Injectable; Solution |
Route | Injection; Oral |
Strength | 2mg/ml; 1mg/ml; 8mg; 10mg/ml; 4mg; 4mg/ml; 12mg; 2mg; 16mg; 5mg/5ml |
Market Status | Prescription |
Company | Hospira; Actavis Labs Fl; Mallinckrodt; Roxane; Lannett; Elite Labs; Akorn; Barr |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-06
Pay. Date : 2014-05-28
DMF Number : 19846
Submission : 2006-10-06
Status : Active
Type : II
Certificate Number : R1-CEP 2004-265 - Rev 02
Issue Date : 2017-02-27
Type : Chemical
Substance Number : 2099
Status : Valid
NDC Package Code : 49812-0124
Start Marketing Date : 1995-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2022-04-25
Registration Number : 20220204-211-J-1228(A)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Available Reg Filing : ROW |
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-06
Pay. Date : 2012-11-23
DMF Number : 19561
Submission : 2006-06-29
Status : Active
Type : II
Certificate Number : R1-CEP 2006-169 - Rev 04
Issue Date : 2021-03-25
Type : Chemical
Substance Number : 2099
Status : Valid
NDC Package Code : 51634-0057
Start Marketing Date : 2006-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-13
Pay. Date : 2012-11-27
DMF Number : 25766
Submission : 2012-07-25
Status : Active
Type : II
NDC Package Code : 0406-3222
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-18
Pay. Date : 2013-02-14
DMF Number : 22082
Submission : 2008-10-01
Status : Active
Type : II
Certificate Number : R1-CEP 2008-079 - Rev 02
Issue Date : 2021-12-02
Type : Chemical
Substance Number : 2099
Status : Valid
NDC Package Code : 0792-0632
Start Marketing Date : 2008-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17501
Submission : 2004-06-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28804
Submission : 2014-12-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7237
Submission : 1987-11-20
Status : Inactive
Type : II
NDC Package Code : 0406-3222
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18834
Submission : 2005-09-30
Status : Inactive
Type : II
NDC Package Code : 0406-3222
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7011
Submission : 1987-06-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-06
Pay. Date : 2014-05-28
DMF Number : 19846
Submission : 2006-10-06
Status : Active
Type : II
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-06
Pay. Date : 2012-11-23
DMF Number : 19561
Submission : 2006-06-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17501
Submission : 2004-06-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7011
Submission : 1987-06-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-13
Pay. Date : 2012-11-27
DMF Number : 25766
Submission : 2012-07-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18834
Submission : 2005-09-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7237
Submission : 1987-11-20
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-18
Pay. Date : 2013-02-14
DMF Number : 22082
Submission : 2008-10-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7071
Submission : 1987-07-13
Status : Inactive
Type : II
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
About the Company : Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction & pain management. We manufacture & market a wide range of APIs & formul...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
About the Company : OmnisMed Pharmaceuticals believes that good healthcare must be accessible to everyone; That is the core of our philosophy. We are experts in providing a wide range of high-quality ...
About the Company : We are the largest pharmaceutical company in Slovakia with site originally established in the 1940s. Our multi-purpose headquarters is easily reachable from all central European hu...
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 10MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 10MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 10MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 50MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Packaging :
Regulatory Info : Dossier Availability- Q2 2017
Dosage : Solution for Injection
Dosage Strength : 50MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Austria
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Dilid
Dosage Form : TABLET
Dosage Strength : 2MG
Packaging : 100 T
Approval Date :
Application Number : 78439
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 100 T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 2MG
Brand Name : Dilid
Approval Date :
Application Number : 78439
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Dilid
Dosage Form : INJECTION
Dosage Strength : 1MG
Packaging : 1mL x 10A
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 1mL x 10A
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 1MG
Brand Name : Dilid
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : Dilid
Dosage Form : INJECTION
Dosage Strength : 2MG
Packaging : 2mL x 10A
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 2mL x 10A
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 2MG
Brand Name : Dilid
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Dosage : Tablet
Dosage Strength : 2MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Extended Release Table...
Dosage Strength : 12MG
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Dosage : Extended Release Table...
Dosage Strength : 12MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hydromorphone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydromorphone Hydrochloride, including repackagers and relabelers. The FDA regulates Hydromorphone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydromorphone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydromorphone Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydromorphone Hydrochloride supplier is an individual or a company that provides Hydromorphone Hydrochloride active pharmaceutical ingredient (API) or Hydromorphone Hydrochloride finished formulations upon request. The Hydromorphone Hydrochloride suppliers may include Hydromorphone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Hydromorphone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydromorphone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydromorphone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Hydromorphone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Hydromorphone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydromorphone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Hydromorphone Hydrochloride USDMF includes data on Hydromorphone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydromorphone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydromorphone Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hydromorphone Hydrochloride Drug Master File in Japan (Hydromorphone Hydrochloride JDMF) empowers Hydromorphone Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hydromorphone Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Hydromorphone Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hydromorphone Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydromorphone Hydrochloride Drug Master File in Korea (Hydromorphone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydromorphone Hydrochloride. The MFDS reviews the Hydromorphone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Hydromorphone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydromorphone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydromorphone Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydromorphone Hydrochloride suppliers with KDMF on PharmaCompass.
A Hydromorphone Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Hydromorphone Hydrochloride Certificate of Suitability (COS). The purpose of a Hydromorphone Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydromorphone Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydromorphone Hydrochloride to their clients by showing that a Hydromorphone Hydrochloride CEP has been issued for it. The manufacturer submits a Hydromorphone Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydromorphone Hydrochloride CEP holder for the record. Additionally, the data presented in the Hydromorphone Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydromorphone Hydrochloride DMF.
A Hydromorphone Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydromorphone Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydromorphone Hydrochloride suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydromorphone Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydromorphone Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydromorphone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydromorphone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydromorphone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydromorphone Hydrochloride suppliers with NDC on PharmaCompass.
Hydromorphone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydromorphone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydromorphone Hydrochloride GMP manufacturer or Hydromorphone Hydrochloride GMP API supplier for your needs.
A Hydromorphone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Hydromorphone Hydrochloride's compliance with Hydromorphone Hydrochloride specifications and serves as a tool for batch-level quality control.
Hydromorphone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Hydromorphone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydromorphone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydromorphone Hydrochloride EP), Hydromorphone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydromorphone Hydrochloride USP).
LOOKING FOR A SUPPLIER?